Saudi Journal of Kidney Diseases and Transplantation

EDITORIAL
Year
: 1996  |  Volume : 7  |  Issue : 3  |  Page : 277--282

Hepatorenal Syndrome


Paul Sweny 
 Department of Nephrology and Transplantation, Trie Royal Free Hospital, London, United Kingdom

Correspondence Address:
Paul Sweny
Department of Nephrology and Transplantation, The Royal Free Hospital, Pond Street, London MW3 2GQ
United Kingdom

The hepatorenal syndrome (HRS) is a common complication of advanced liver disease. Careful management can reduce the risk of this functional renal failure developing in the vulnerable group of patients. Potentially nephrotoxic agents (drugs, x-ray contrast, etc.) need to be avoided wherever possible. It is likely that sympathetic overactivity, endotoxin, nitric oxide and endothelin, together with perturbed arachidonic acid metabolism, are closely involved in pathogenesis. Many of the associated abnormalities in HRS can be explained on the basis of an inadequate effective arterial blood volume and the resulting attempts at compensatory homeostasis. Medical management is disappointing, but trans-cutaneous intra-hepatic portal systemic shunting may help. Successful orthotopic liver transplantation is curative.


How to cite this article:
Sweny P. Hepatorenal Syndrome.Saudi J Kidney Dis Transpl 1996;7:277-282


How to cite this URL:
Sweny P. Hepatorenal Syndrome. Saudi J Kidney Dis Transpl [serial online] 1996 [cited 2020 Oct 24 ];7:277-282
Available from: https://www.sjkdt.org/article.asp?issn=1319-2442;year=1996;volume=7;issue=3;spage=277;epage=282;aulast=Sweny;type=0